Lobbying Activity Report

1698-49778

Organization: Hoffmann-La Roche Limited
Associated registration: 9040-1698-37
Lobbying Activity date: 2026-02-18
Arranged a meeting: No
Posted date: 2026-03-12

In-house lobbyists who participated in the lobbying activity: Robyn Henwood
Senior Public Office Holders who were lobbied in this activity: Sue Bouma, Executive Director, Clinical Services & Evaluation
Pharmaceutical, Laboratory & Blood Services Division, Health

John Capelli, Executive Director
Pharmaceutical Policy, Legislation & Engagement Branch, Health

Tijana Fazlagic, Executive Director
PharmaCare Benefits Branch, Health

Sarah Pugh, Executive Director
Health

Ian Rongve, ADM
Ministry of Health, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Work with the Ministry of Health regarding public reimbursement of Roche’s innovative pharmaceutical products, and ensure any changes to pharmaceutical legislation support appropriate government reimbursement of innovative pharmaceuticals.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Health, Hospitals
 
Senior officer who filed this Lobbying Activity Report: Brigitte Nolet
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Date Modified: